[2]
Giliyar, C.; Fikstad, D.T.; Tyavanagimatt, S. Challenges and opportunities in oral delivery of poorly water-soluble drugs. Drug Del. Technol., 2006, 6, 57-63.
[12]
Spireas, S. Liquisolid systems and methods of preparing same. WO1997047290A1, 2002.
[13]
Vajir, S.; Sahu, V.; Ghuge, N.; Bakde, B.V. Effect of dissolution rate by liquisolid compact approach: an overview. Int. J. Pharm. Chem. Sci., 2012, 1, 1013-1018.
[15]
Pezzini, B.R.; Beringhs, A.O.; Ferraz, H.G.; Silva, M.A.S.; Stulzer, H.K.; Sonaglio, D. Liquisolid technology applied to pellets. 7th Int. Granulation Workshop, 2015.
[30]
Propst, C.W. Granulation characterization. In handbook of pharmaceutical granulation technology; CRC Press, 2016, pp. 485-502.
[32]
Patel, K.J.; Patel, Y.K. Liquisolid technique: enhancement of solubility and dissolution rate: a modern review. Int. J. Pharm. Res. Biomed. Sci., 2014, 3, 397-407.
[44]
Karmarkar, A.B.; Gonjari, I.D.; Hosmani, A.H.; Dhabale, P.N.; Bhise, S.B. Dissolution rate enhancement of fenofibrate using liquisolid tablet technique. Lat. Am. J. Pharm., 2009, 28, 219-225.
[45]
Rowe, R.C.; Sheskey, P.J.; Quinn, M. Handbook of pharmaceutical excipients, 7th ed; Pharm. Dev. Technol, 2013, p. 18.
[52]
Meyer, J.; Frahn, S.; Ettlinger, M. Lacquer formulations. CA2496936C, 2008.
[53]
Yadav, V.B.; Yadav, A.V. Improvement of solubility and dissolution of indomethacin by liquisolid and compaction granulation technique. J. Pharm. Sci. Res., 2009, 1, 44-51.
[54]
Bhise, A.S.; Ahirrao, S.; Rahane, A.D.; Kshirsagar, S. Solubility enhancement of poorly water-soluble drugs using liquisolid technique. Indian J. Drugs., 2018, 6, 152-164.
[64]
Balaji, A.; Umashankar, M.S.; Kavitha, B. Liquisolid technology- A latest review. Int. J. App. Pharm., 2014, 6, 11-19.
[69]
Yadav, V.B.; Nighute, A.B.; Yadav, A.V.; Bhise, S.B. Aceclofenac size enlargement by non-aqueous granulation with improved solubility and dissolution. Arch. Pharm. Sci. Res., 2009, 1, 115-122.
[70]
Gubbi, S.; Jarag, R. Liquisolid technique for enhancement of dissolution properties of bromhexine hydrochloride. Res. J. Pharm. Techol., 2009, 2, 382-386.
[71]
Darwish, I.A.E.M.; El-Kamel, A.H. Dissolution enhancement of glibenclamide using liquisolid tablet technology. Acta Pharm., 2001, 51, 173-181.
[77]
Chen, X.; Wen, H.; Park, K. Challenges, and new technologies of oral controlled release. Oral controlled release formulation design and drug delivery: theory to practice. JWS, 2010, 16, 257-277.
[78]
Tapaswi, R.D.; Verma, P. Matrix tablets: an approach towards oral extended release drug delivery. Int. J. Pharma. Res. Rev., 2013, 2, 12-24.
[82]
Gonjari, I.D.; Karmarkar, A.B.; Hosmani, A.H. Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets. Dig. J. Nanomater. Biostruct., 2009, 4, 651-661.
[91]
Valadez, J.A.R.; Robles, L.V. Compactibility assessment of direct compression excipients. Prosolv Easytab. Int. J. Pharm. Pharm. Sci., 2014, 6, 258-264.
[97]
Nadavadekar, P.; Koliyote, S. Coprocessed excipients for orally disintegrating dosage form. Int. J. Pharm. Res. Rev., 2014, 3, 95-100.